Monthly Archives: July 2022

//July

Contractor Notice: Expiry of SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Premique® low dose 0.3mg/1.5mg modified-release tablets is now available to meet normal demand. As a result the Serious Shortage Protocol, SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets expires at 23.59pm on Friday 29 July 2022. After this date, any prescriptions for [...]

The post Contractor Notice: Expiry of SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets appeared first on PSNC Website.

By |July 28th, 2022|hrt, Lexpos News, premique, ssp021|Comments Off on Contractor Notice: Expiry of SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets
Read More

SSP for Combisal®125mcg/25mcg inhalers extended

Update 28/09/2022 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Combisal®125mcg/25mcg inhalers (SSP034). SSP034 for Combisal®125mcg/25mcg inhalers was previously expected to expire on 28 September 2022 but the end date has been further extended to Friday 7 October 2022. Update 19/08/2022 – The [...]

The post SSP for Combisal®125mcg/25mcg inhalers extended appeared first on PSNC Website.

By |July 28th, 2022|combisal, Lexpos News, ssp, ssp034|Comments Off on SSP for Combisal®125mcg/25mcg inhalers extended
Read More

CEO Blog: July 2022

In a new update to the sector, PSNC’s CEO, Janet Morrison, talks about some of the very serious challenges that she has seen facing community pharmacies in England, and the urgent need to put the sector on a sustainable footing. As the NHS continues to struggle, Janet recognises the incredible efforts of pharmacy teams who are operating well-beyond capacity to continue [...]

The post CEO Blog: July 2022 appeared first on PSNC Website.

By |July 28th, 2022|Lexpos News|Comments Off on CEO Blog: July 2022
Read More

Magnesium glycerophosphate 97.2mg (4mmol) chewable tablets reclassified as a special container

Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of a Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets. From August 2022, this product has been added to Part VIII of the Drug Tariff with special container status as it meets the relevant criteria as set out [...]

The post Magnesium glycerophosphate 97.2mg (4mmol) chewable tablets reclassified as a special container appeared first on PSNC Website.

By |July 27th, 2022|Drug Tariff, Lexpos News, special container|Comments Off on Magnesium glycerophosphate 97.2mg (4mmol) chewable tablets reclassified as a special container
Read More

Get ready for the 2022 Workforce Survey

The 2022 Community Pharmacy Workforce Survey will take place in the autumn and all pharmacy contractors will be asked to submit data to support workforce planning for the sector. The survey was first undertaken in 2017 and it was repeated last year. Recognising the recruitment challenges that contractors are facing, from this year, the survey [...]

The post Get ready for the 2022 Workforce Survey appeared first on PSNC Website.

By |July 27th, 2022|hee, Lexpos News, Workforce|Comments Off on Get ready for the 2022 Workforce Survey
Read More

Recent Comments

    © Copyright 2017 | Lexcom Systems Ltd